Nkarta Inc (NASDAQ: NKTX) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

Nkarta Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $10.21 and fluctuated between $10.27 as its day high and $8.87 as its day low. The current market capitalization of Nkarta Inc is $501.00M. A total of 1.36 million shares were traded on the day, compared to an average of 2.01M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, NKTX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 7 SELLs from insiders. Insiders purchased 0 shares during that period but sold 5,361.

In the most recent transaction, HASTINGS PAUL J sold 9,697 shares of NKTX for 8.74 per share on Jan 16. After the transaction, the Chief Executive Officer now owns 390,507 company shares. In a previous transaction on Jan 16, Trager James sold 4,560 shares at 8.74 per share. NKTX shares that Chief Scientific Officer owns now total 153,558.

Among the insiders who sold shares, Hager Alicia J. disposed of 4,554 shares on Jan 16 at a per-share price of $8.74. This resulted in the Chief Legal Officer holding 107,942 shares of NKTX after the transaction. In another insider transaction, Shook David sold 3,552 shares at $8.74 per share on Jan 16. Company shares held by the Chief Medical Officer now total 114,980.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for NKTX in the last 3 months, the mean price target is $14.17 with high estimates of $22.00 and low estimates of $9.00. In terms of 52-week highs and lows, NKTX has a high of $11.62 and a low of $1.28.

As of this writing, NKTX has an earnings estimate of -$0.55 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.41 per share and a lower estimate of -$0.69.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NKTX’s latest balance sheet shows that the firm has $238.09M in Cash & Short Term Investments as of fiscal 2021. There were $12.46M in debt and $12.94M in liabilities at the time. Its Book Value Per Share was $6.05, while its Total Shareholder’s Equity was $250.97M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NKTX is Buy with a score of 4.89.

Most Popular

Related Posts